0,959  0,004  Apoptosis agonist
0,924  0,005  Antiinflammatory
0,910  0,004  Antineoplastic (lung cancer)
0,858  0,009  Transcription factor NF kappa B inhibitor
0,848  0,004  Nitric oxide antagonist
0,841  0,005  Antileukemic
0,836  0,006  Antineoplastic (breast cancer)
0,829  0,004  Antineoplastic (melanoma)
0,827  0,004  Hepatic disorders treatment
0,827  0,008  Caspase 9 stimulant
0,800  0,007  Antineoplastic (colorectal cancer)
0,795  0,007  Antineoplastic (colon cancer)
0,787  0,005  Antineoplastic (ovarian cancer)
0,780  0,005  Antineoplastic (cervical cancer)
0,773  0,003  Hepatoprotectant
0,762  0,004  Antineoplastic (pancreatic cancer)
0,743  0,008  Chemopreventive
0,739  0,007  Prostate cancer treatment
0,716  0,006  5 Hydroxytryptamine release stimulant
0,708  0,003  Antineoplastic (endocrine cancer)
0,673  0,006  AR expression inhibitor
0,654  0,003  Protein-tyrosine phosphatase 1B inhibitor
0,648  0,006  Antineoplastic (glioma)
0,632  0,004  Protein-tyrosine phosphatase inhibitor
0,611  0,004  ICAM1 expression inhibitor
0,613  0,009  Caspase 3 stimulant
0,604  0,009  Apoptosis antagonist
0,609  0,014  Sensitization
0,563  0,003  Interferon gamma antagonist
0,575  0,029  TNF expression inhibitor
0,544  0,011  Hypoxia-inducible factor 1 alpha inhibitor
0,539  0,007  Antihypoxic
0,548  0,018  Cytotoxic
0,538  0,009  Antineoplastic (glioblastoma multiforme)
0,533  0,005  Contraceptive
0,532  0,005  Transcription factor STAT3 inhibitor
0,535  0,014  Antineoplastic (multiple myeloma)
0,516  0,008  Antineoplastic (liver cancer)
0,505  0,004  Antiviral (Influenza A)
0,496  0,005  Antiacne
0,493  0,005  Prostate disorders treatment
0,493  0,008  Transcription factor STAT inhibitor
0,474  0,005  Antiviral (Influenza)
0,485  0,020  NOS2 expression inhibitor
0,472  0,008  Prostatic (benign) hyperplasia treatment
0,472  0,010  Antineoplastic (sarcoma)
0,482  0,022  NOS3 expression inhibitor
0,464  0,009  Hair growth stimulant
0,478  0,023  Antioxidant
0,475  0,022  Cardiovascular analeptic
0,453  0,027  Chemoprotective
0,426  0,002  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,426  0,005  Antiviral (Hepatitis B)
0,442  0,021  UGT2B4 substrate
0,474  0,058  Cyclophilin D inhibitor
0,474  0,058  Antidiabetic
0,431  0,021  Antineoplastic (lymphoma)
0,416  0,014  Abortion inducer
0,433  0,043  Cholesterol antagonist
0,412  0,025  Hypoglycemic
0,390  0,004  Contraceptive female
0,430  0,046  Vasodilator, peripheral
0,398  0,015  Antineoplastic (bladder cancer)
0,391  0,020  Sodium/bile acid cotransporter inhibitor
0,392  0,028  Tumour necrosis factor alpha release inhibitor
0,374  0,011  Lipocortins synthesis antagonist
0,400  0,044  Antihypercholesterolemic
0,386  0,031  Proliferative diseases treatment
0,355  0,003  Aldosterone antagonist
0,360  0,010  Liver fibrosis treatment
0,363  0,023  Wound healing agent
0,358  0,020  P-glycoprotein inhibitor
0,346  0,009  Insulin secretagoues
0,366  0,029  Vascular (periferal) disease treatment
0,346  0,011  Gastrin inhibitor
0,345  0,015  Antiviral (Hepatitis)
0,348  0,022  UGT1A4 substrate
0,339  0,020  Antiviral (Herpes)
0,323  0,009  Cholesterol synthesis inhibitor
0,327  0,016  Phospholipase C inhibitor
0,366  0,060  Immunostimulant
0,341  0,035  Antiparasitic
0,327  0,021  UGT2B7 substrate
0,332  0,033  Antiulcerative
0,339  0,040  Cardiodepressant
0,358  0,063  Bone diseases treatment
0,347  0,053  CYP3A4 inhibitor
0,298  0,004  Inducible nitric-oxide synthase inhibitor
0,312  0,020  Diuretic
0,329  0,048  Antineoplastic (non-small cell lung cancer)
0,309  0,030  Antihelmintic
0,307  0,049  Antineoplastic (renal cancer)
0,310  0,053  Antipyretic
0,318  0,062  Interleukin 2 agonist
0,346  0,092  Antipruritic, allergic
0,254  0,005  Transcription factor NF kappa B stimulant
0,255  0,006  AMP-activated protein kinase stimulant
0,306  0,061  Teratogen
0,282  0,039  Antiviral (HIV)
0,268  0,025  Insulin sensitizer
0,253  0,011  Farnesoid X receptor antagonist
0,311  0,072  Antineoplastic (brain cancer)
0,294  0,056  Antiprotozoal (Leishmania)
0,284  0,050  Antineoplastic (lymphocytic leukemia)
0,269  0,040  UGT1A1 substrate
0,253  0,026  UGT2B15 substrate
0,230  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,235  0,010  Cyclooxygenase 3 inhibitor
0,253  0,030  Antineoplastic (squamous cell carcinoma)
0,231  0,010  Androgen antagonist
0,235  0,018  UGT2B10 substrate
0,320  0,103  Immunosuppressant
0,288  0,072  Antiosteoporotic
0,259  0,046  UDP-glucuronosyltransferase substrate
0,229  0,019  Antitussive
0,249  0,039  Neurotrophic factor enhancer
0,291  0,084  Antifungal
0,258  0,052  Antihypertriglyceridemic
0,233  0,027  Antiviral (Hepatitis C)
0,287  0,083  Analeptic
0,220  0,017  Antihemorrhagic
0,206  0,005  5-Alpha-reductase inhibitor
0,281  0,080  Cardioprotectant
0,216  0,019  Arachidonic acid antagonist
0,261  0,069  Embryotoxic
0,198  0,007  CDC25A inhibitor
0,269  0,081  CYP2C19 substrate
0,193  0,005  Anabolic
0,217  0,031  UGT2B9 substrate
0,226  0,046  Antipruritic, non-allergic
0,217  0,039  Antineoplastic (carcinoma)
0,212  0,036  Acute respiratory distress syndrome (ARDS) treatment
0,241  0,066  UGT1A6 substrate
0,210  0,035  Skin whitener
0,246  0,072  Angiogenesis stimulant
0,267  0,093  Respiratory analeptic
0,267  0,094  Antipsoriatic
0,182  0,012  Contraceptive male
0,170  0,002  Heme oxygenase stimulant
0,167  0,009  CC chemokine 6 receptor antagonist
0,181  0,025  Endometrios treatment
0,186  0,033  DNA polymerase I inhibitor
0,154  0,004  RNA-directed RNA polymerase stimulant
0,202  0,053  LDLR expression enhancer
0,172  0,028  Liver cirrhosis treatment
0,240  0,096  Lipoprotein disorders treatment
0,154  0,012  Postmenopausal disorders treatment
0,188  0,047  Lipid peroxidase inhibitor
0,173  0,032  Adenylate cyclase stimulant
0,145  0,007  Na+ K+ transporting ATPase inhibitor
0,152  0,014  UGT2B11 substrate
0,207  0,071  Anesthetic general
0,151  0,017  ABCA1 expression enhancer
0,142  0,012  Estrogen agonist
0,161  0,036  Pregnane X receptor agonist
0,212  0,088  Free radical scavenger
0,149  0,027  Antiinfertility, female
0,145  0,024  Nitric-oxide synthase inhibitor
0,173  0,053  Protein kinase stimulant
0,171  0,051  Anesthetic
0,135  0,015  Aromatase inhibitor
0,195  0,075  Non-steroidal antiinflammatory agent
0,274  0,155  Antibacterial
0,182  0,064  Antirickettsial
0,173  0,057  Melanin inhibitor
0,126  0,015  Glycine receptor antagonist
0,138  0,029  Estrogen antagonist
0,109  0,004  Lipocortins synthesis agonist
0,215  0,110  UGT1A9 substrate
0,170  0,068  Antihelmintic (Nematodes)
0,248  0,151  CYP2C9 substrate
0,137  0,041  Choleretic
0,124  0,028  Estrogen receptor beta antagonist
0,215  0,119  Antidiabetic (type 2)
0,166  0,072  UGT1A3 substrate
0,106  0,013  Androgen agonist
0,097  0,004  Progesterone agonist
0,167  0,078  Muscle relaxant
0,125  0,037  Antineoplastic antibiotic
0,170  0,083  Diabetic nephropathy treatment
0,171  0,085  Carcinogenic
0,151  0,067  Antidiabetic (type 1)
0,108  0,026  3C-Like protease (SARS coronavirus) inhibitor
0,233  0,151  Vasodilator, coronary
0,135  0,054  Growth stimulant
0,272  0,193  Alzheimer's disease treatment
0,222  0,145  GST M1-1 substrate
0,156  0,080  Interleukin 6 antagonist
0,128  0,054  Alcohol dehydrogenase substrate
0,218  0,146  CTGF expression inhibitor
0,164  0,092  Platelet adhesion inhibitor
0,083  0,012  Postcoital contraceptive
0,076  0,007  Glucocorticoid antagonist
0,084  0,016  Phosphorylase inhibitor
0,120  0,051  Expectorant
0,178  0,110  Antineoplastic enhancer
0,137  0,071  Psychosexual dysfunction treatment
0,070  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,079  0,014  Diacylglycerol O-acyltransferase inhibitor
0,089  0,025  Anticholelithogenic
0,078  0,015  Estrogen receptor beta agonist
0,115  0,054  HDL-cholesterol increasing
0,113  0,053  Protease inhibitor
0,102  0,042  Ornithine decarboxylase inhibitor
0,133  0,074  Antifungal enhancer
0,129  0,072  Cyclooxygenase 1 inhibitor
0,064  0,006  5-Alpha-reductase 1 inhibitor
0,061  0,006  Estrone sulfatase inhibitor
0,062  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,072  0,020  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,107  0,056  Sulfotransferase substrate
0,190  0,140  Amyotrophic lateral sclerosis treatment
0,133  0,084  Skeletal muscle relaxant
0,099  0,051  Bile acid receptor antagonist
0,216  0,167  CYP3A4 substrate
0,077  0,031  CDC25B inhibitor
0,074  0,028  Nitric oxide donor
0,060  0,015  Estrogen receptor alpha agonist
0,168  0,123  Antialcoholic
0,063  0,018  Estradiol 17 beta-dehydrogenase inhibitor
0,108  0,069  SULT1A1 substrate
0,093  0,054  Actinic keratosis treatment
0,046  0,009  Cholesterol ester transfer protein antagonist
0,068  0,032  Transcription factor AP-1 inhibitor
0,042  0,008  5-Alpha-reductase 2 inhibitor
0,109  0,075  Microtubule formation inhibitor
0,217  0,183  Histamine release inhibitor
0,057  0,023  Mineralocorticoid receptor antagonist
0,072  0,039  SULT2A1 substrate
0,047  0,015  p53 inhibitor
0,099  0,071  Topoisomerase I inhibitor
0,105  0,078  TRPA1 agonist
0,228  0,201  Alpha-glucosidase inhibitor
0,032  0,006  Corticosteroid-like
0,193  0,166  5 Hydroxytryptamine uptake stimulant
0,059  0,033  Acetyl-CoA transferase 2 inhibitor
0,201  0,175  Antithrombotic
0,034  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,111  0,088  Acetylcholinesterase inhibitor
0,205  0,182  Ca(v)3.3 blocker
0,026  0,004  Telomerase stimulant
0,042  0,021  Farnesoid X receptor agonist
0,111  0,091  Antihyperlipoproteinemic
0,046  0,028  Parathyroid hormone antagonist
0,075  0,058  Estrogen receptor alpha antagonist
0,039  0,023  Progesterone antagonist
0,074  0,058  Keratolytic
0,035  0,021  Tubulin agonist
0,205  0,191  FMO1 substrate
0,124  0,110  Phospholipase A2 inhibitor
0,017  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,058  0,046  Bcl-xL inhibitor
0,025  0,014  Retinoid X gamma receptor agonist
0,101  0,090  Antiviral (SARS coronavirus)
0,101  0,090  Antiviral (Coronavirus)
0,028  0,017  Hedgehog signaling activator
0,092  0,082  Antiprotozoal (Toxoplasma)
0,093  0,083  UGT2B1 substrate
0,036  0,027  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,049  0,040  Anesthetic inhalation
0,027  0,018  Retinoid X gamma receptor antagonist
0,148  0,140  Antiparkinsonian, rigidity relieving
0,163  0,155  Interleukin agonist
0,083  0,076  SULT1E1 substrate
0,097  0,089  Topoisomerase II inhibitor
0,048  0,040  CD45 antagonist
0,050  0,042  Acetyl-CoA transferase inhibitor
0,022  0,016  Retinoic acid gamma receptor agonist
0,020  0,014  Retinoic acid alpha receptor antagonist
0,067  0,062  Glycine receptor agonist
0,007  0,003  Transcortin receptor antagonist
0,013  0,009  Glucocorticoid agonist
0,036  0,034  Retinoic acid alpha receptor agonist
0,041  0,040  Microtubule stabilization
0,067  0,067  Cushing's syndrome treatment

